长沙招聘

工作职责:

Position Purpose：

The Hub Submission Manager is accountable for operational management of regional and/or national regulatory dossiers to designated Health Authorities (HA’s)

Based within WSR Submission Management, this role sits within a team working to tight, business-critical deadlines within a highly regulated environment. Primary focus is on allocated region/ countries, with additional responsibility to support other "location"s through utilization of global tools.

On behalf of Worldwide Safety & Regulatory (WSR), lead and manage logistical and technical aspects, ensuring development and delivery of X-regional, regional and/or national regulatory dossiers - initial application and subsequent lifecycle updates (compliance and maintenance).

Execute, through use of standards and tools, designated operational tasks e.g. submission planning, document receipt, translation management, technical build and submittal to HA or via the applicable Pfizer country office, conforming to regulatory submission milestones and applicable regulatory obligations.

Given the scope of international work, critical features of this role are the ability to successfully interface with multiple cultures and, to recognize and exploit opportunities to use scale, cloning and repurposing dossiers for worldwide markets where feasible.

任职资格:

Primary Responsibilities ：

Senior Associate

Drive submission coordination activities for assigned products and/or regulatory procedures as appropriate. Partnering with product teams and/or third-party partners, the incumbent will be responsible for project management of activities, in support of regional and national regulatory submissions component build and delivery.

Delivering project specific Pfizer electronic and paper regulatory submissions. Including co-ordination and execution of solutions that meet unique requirements of each submission and national market, management of product delivery to regulatory agencies and ensuring subsequent archival.

Ongoing liaison with Project Team and country representatives to ensure paper and electronic submission requirements, translation requirements and timelines are mutually understood and in line with corporate standards and deadlines for dossier delivery to regional and national markets.

Actively participate in the definition, investigation and implementation of national, regional and global process efficiencies for paper and electronic submission execution, including the evaluation of current processes.

Completion of assignments and tasks within a specific task force/project associated with electronic and paper submissions.

Help interpret regulatory guidelines to produce business requirements and ensure that those requirements are implemented where appropriate at local level.

Contribute to effective forecasting and management of project specific resources utilizing flexible resourcing, and global load sharing as normal business practice.

Adhere to the appropriate use of technical tools, through use of working practices and QC/QA regimes, such that regulatory and internal compliance is preserved.

Operate as Subject Matter Expert in dossier types and/or processes with responsibility for training and mentoring fellow colleagues

Escalates, informs, and resolves any issues that may impact submission builds or the logistics of global submission delivery to regional partners or Health Authorities.

Promotes the use of Document Management and Archival systems and standard document authoring and publishing processes, partnering with supplier groups as necessary in order to produce timely delivery of submission/archive ready components.

#LI-PFE

On October 31, 2005, Pfizer announced the official opening of China Research and Development Center (CRDC) in Shanghai. Pfizer Global Research and Development’s Center is mainly engaged in drug development activities. Much of the facility's capacity is devoted to the study design, data management and statistical analysis of global phase I-IV clinical trials, as well as the clinical study report process. In addition, CRDC is a part of Pfizer global Safety and Risk Management and covers the functions of safety data processing and assessment. The center also trains Pfizer employees in China and throughout the Asia region in internationally recognized Good Clinical Practice standards.
辉瑞公司于2005年10月31日宣布辉瑞中国研发中心正式在上海揭幕。辉瑞中国研发中心主要为全球辉瑞药物开发提供支持工作。大部分的功能是围绕在I-IV期临床试验研究设计、数据管理和生物统计分析、以及临床试验报告的部分准备工作。此外，该中心是辉瑞全球安全和风险管理部的一个分支，负责安全数据处理和评估工作。研发中心还将为辉瑞公司在中国及亚洲的其它运营部门的员工提供国际标准的临床试验管理规范(GCP)的技术培训。